Amarantus Bioscience - AMBS
Patented MANF technology to treat a myriad of diseases including Parkinson's disease.
1,500% upside within three months.
Starting to move on recent news.
Starting to move again.
Read the recent Yahoo news.
One of the co-founders of Amgen recently joined the company's board of directors.
The market is just starting to discover the tremendous upside that the company offers.
The "Human Brain Mapping Project" will substantially increase the value of the company's patented MANF technology.
Potential buyout target.